[1]
Sajith, M. et al. 2015. COST OF THERAPY INCURRED FOR TUBERCULOSIS PATIENTS RECEIVING DIRECTLY OBSERVED THERAPY (DOT). International Journal of Pharmacy and Pharmaceutical Sciences. 7, 11 (Oct. 2015), 141–144.